The different effects of recombinant human tumor necrosis factor on rat fibrosarcoma sublines Junichi IshiharaNagahiro SaijoTerumi Takahashi Original Articles Pages: 185 - 189
Influence of α-interferon therapy on blood lymphoid cells Stefan EinhornPatrik LingJerzy Wasserman Original Articles Pages: 190 - 196
Canine lymphoma-associated antigens defined by murine monoclonal antibodies Zenon SteplewskiK. Ann JeglumNancy Weintraub Original Articles Pages: 197 - 201
Comparison of multiple anti-CEA immunotoxins active against human adenocarcinoma cells Larissa V. LevinThomas W. GriffinDarrow E. Haagensen Jr. Original Articles Pages: 202 - 206
Oncostatic and immunomodulatory effects of a glycoprotein fraction from water extract of abalone, Haliotis discus hannai Hiroyuki UchidaTakuma SasakiHisao Kamiya Original Articles Pages: 207 - 212
Natural killer (NK) cell immunodeficiency in patients with chronic myelogenous leukemia Yoshiaki FujimiyaWeng-Cheng ChangPaul K. Pattengale Original Articles Pages: 213 - 220
High-dose, unlabeled, nonspecific antibody pretreatment: influence on specific antibody localization to human melanoma xenografts Richard L. WahlBarry S. WilsonWilliam H. Beierwaltes Original Articles Pages: 221 - 224
In vivo delayed rejection of tumors and inhibition of delayed - type hypersensitivity by HT-29 human colonic adenocarcinoma cell line Gilbert J. PommierFrançoise L. GarrousteMaryse M. Remacle-Bonnet Original Articles Pages: 225 - 230
Depression of cell-mediated immunity by tumour cell products: induction of resistance by immunotherapeutically active extracts of bovine ocular squamous cell carcinoma Margaret NelsonD. S. NelsonP. A. Jennings Original Articles Pages: 231 - 236
Defective T helper activity in the spleen of BALB/c mice immune to a syngeneic fibrosarcoma Laura GrazioliMarialuisa SensiGiorgio Parmiani Original Articles Pages: 237 - 243
Phase II trial of MVE-II in metastic malignant melanoma John RinehartJulie LaForgeJames Neidhart Original Articles Pages: 244 - 246
Lysosome rich cells contain the lytic activity of lymphokine-activated killer cell populations Ravin AgahHungyi ShauAmitabha Mazumder Original Articles Pages: 247 - 252
Augmentation of natural cell activity in tumor-bearing and normal mice by MVE-2 Wladyslaw BudzynskiMichael ChirigosEilene Gruys Original Articles Pages: 253 - 258
Augmentation of the generation of cell-mediated cytotoxicity in culture by mitomycin C Tsuyoshi AkiyoshiShinya ArinagaHideo Tsuji Original Articles Pages: 259 - 262
A monoclonal antibody (Po66) directed against human lung squamous cell carcinoma immunolocalization of tumour xenografts in nude mice Léontine DazordDominique BourelLouis Toujas Original Articles Pages: 263 - 268
The anti-tumour efficacy of human recombinant interleukin 2 J. BubeníkM. Indrová Original Articles Pages: 269 - 271
Expression of HLA-DR antigens on tumour cells does not contribute to skin reactivity to autologous cholesteryl hemisuccinate (CHS)-treated tumour cells in patients with metastatic melanoma Marta MunzarováDaniela ZemanováJiří Bártek Short Communication Pages: 272 - 274